StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.19−0.02 (-10.00%)

Close on Nov 18, 2026Market cap $852.76KP/E –Yield –

Oragenics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Oragenics's revenue for the twelve months ending Dec 31, 2023 was $37.65K, down 71.4% year over year. For fiscal 2023 it was $37.65K, down 71.4% from the year before. Over ten years it grew -29.9% a year on average. The highest annual figure on record is $1.44M in fiscal 2011.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023$37.65K-71.4%
FY2022Dec 31, 2022$131.52K+51.2%
FY2021Dec 31, 2021$86.99K–
FY2017Dec 31, 2017$0–
FY2016Dec 31, 2016$0–
FY2015Dec 31, 2015$0-100.0%
FY2014Dec 31, 2014$939.93K-8.9%
FY2013Dec 31, 2013$1.03M-22.5%
FY2012Dec 31, 2012$1.33M-7.8%
FY2011Dec 31, 2011$1.44M+10.4%
FY2010Dec 31, 2010$1.31M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$0–
Q3 FY2023Sep 30, 2023$7.47K-91.3%
Q2 FY2023Jun 30, 2023$13.16K-56.7%
Q1 FY2023Mar 31, 2023$17.02K+12.9%
Q4 FY2022Dec 31, 2022$0–
Q3 FY2022Sep 30, 2022$86.05K–
Q2 FY2022Jun 30, 2022$30.39K–
Q1 FY2022Mar 31, 2022$15.08K–
Q4 FY2018Dec 31, 2018$0–
Q3 FY2018Sep 30, 2018$0–
Q2 FY2018Jun 30, 2018$0–
Q1 FY2018Mar 31, 2018$0–
Q4 FY2017Dec 31, 2017$0–
Q3 FY2017Sep 30, 2017$0–
Q2 FY2017Jun 30, 2017$0–
Q1 FY2017Mar 31, 2017$0–
Q4 FY2016Dec 31, 2016$0–
Q3 FY2016Sep 30, 2016$0–

More Oragenics figures

See a number that looks wrong?